Hinova Pharmaceuticals

Hinova is a pharmaceutical company that develops and commercializes drugs for the treatment of cancer and metabolic diseases.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Hinova Pharmaceuticals Information

Geographic Data

Hinova Pharmaceuticals headquarters map

Address: No.5, Keyuan South Road

City: Chengdu

State: sichuan province

Zip: 610041

Country: CN

Financial Info

Stage:

series c

Raised Last:

$147M

Raised Total:

$219M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Hinova is a pharmaceutical company that develops and commercializes drugs for the treatment of cancer and metabolic diseases.

Contact Phone:

Contact Email:

Hinova Pharmaceuticals went public on the Other

Listed Exchange:
Other

Ticker Symbol:
688302

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
12/2022 Hongxin Biology Angel Round -
Announced Date Transaction Number of Investors Money Raised Lead Investors
10/2020 Series C $0 CCB International
DNV capital
Founder H Fund
Hongtai Capital Holdings
Huarong Rongde Asset Management
Infinity Group
Sealand Securities
Shenzhen Investment Holdings
Sinopharm-CICC
Tigermed
CCB International
DNV capital
Founder H Fund
Hongtai Capital Holdings
Huarong Rongde Asset Management
Infinity Group
Sealand Securities
Shenzhen Investment Holdings
Sinopharm-CICC
Tigermed
1/2017 Series A -
10/2020 Series C $147M Shenzhen Investment Holdings
Hangzhou Tigermed
Huarong Rongde Asset Management Co Ltd
Sinopharm-CICC
CCB International
Hongtai Aplus
Sealand Innovation
Infinity Group
Founder H Fund
DNV Capital
11/2016 Series A - Haisco
Haisco
7/2019 Series B $0 Fosun Pharma
Chengdu Dingjian New Material Partnership
Hermed Capital
Lang Sheng Investment
Prosper Capital
Silicon Valley Torch Fund
Fosun Pharma
Chengdu Dingjian New Material Partnership
Hermed Capital
Lang Sheng Investment
Prosper Capital
Silicon Valley Torch Fund
1/2014 Angel Round -
9/2020 Series D 1 - Innovitalize Capital
Innovitalize Capital
4/2022 IPO $166.9B
1/2020 Series B 1 $32M GF Xinde Investment Management
GF Xinde Investment Management
7/2019 Series B 6 $40M Hermed Capital
Chengdu Dingjian New Material Partnership
Fosun Pharma
Hermed Capital
Lang Sheng Investment
Prosper Capital
Silicon Valley Torch Fund
1/2017 Series A - Haisco Pharmaceutical
Haisco Pharmaceutical
10/2020 Series C 10 $147.3M CCB International
DNV capital
Founder H Fund
Hongtai Capital Holdings
Huarong Rongde Asset Management
Infinity Group
Sealand Securities
Shenzhen Investment Holdings
Sinopharm-CICC
Tigermed
CCB International
DNV capital
Founder H Fund
Hongtai Capital Holdings
Huarong Rongde Asset Management
Infinity Group
Sealand Securities
Shenzhen Investment Holdings
Sinopharm-CICC
Tigermed
9/2020 Series D 1 - Innovitalize Capital
Innovitalize Capital
11/2016 Series A 1 - Haisco
Haisco
1/2014 Angel Round -
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research